Description

Rimtoregtide is a polypeptide compound which significantly reduces the increase in the levels of amylase and lipase in the blood caused by acute pancreatitis. Rimtoregtide has the potential for the research of pancreatitis and acute pancreatitis (extracted from patent WO2018205233A1).–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)–COVID-19-immunoregulation–C65H101N19O22—-[1]Wang, Liping, et al. Use of polypeptide compound in treatment of acute pancreatitis. Patent WO2018205233A1.–2251722-35-5–1500.61–98.01–CC[C@H](C)[C@H](NC(C)=O)C(NCC(N[C@@H](CC(C)C)C(N[C@@H](CC1=CN=CN1)C(N[C@@H](CC(O)=O)C(N2[C@@H](CCC2)C(N[C@@H](CO)C(N[C@H](C(NCC(N[C@@H]([C@H](O)C)C(N[C@@H](CC(C)C)C(N3[C@@H](CCC3)C(N[C@@H](C)C(NCC(N[C@@H](CO)C(O)=O)=O)=O)=O)=O)=O)=O)=O)CC4=CN=CN4)=O)=O)=O)=O)=O)=O)=O–Inflammation/Immunology–H2O : 100 mg/mL (ultrasonic)–Others—-Others–Peptides